Member Info for Digger01

Were you guys expecting. We all new Erepoxen was the only drug close to potential commercialisation and the time frame was known. So what were you thinking was going to happen on OTCCBB entry ? My broker told me that there would little liquidity before we exited aim. However Baxter are not in to just fund Scott's Salary, or are they ?

It doesnt look like the Erepoxen strategy has been implement or will be until more trial results come in. We expect to begin seeking out-license arrangements for our ErepoXen ® technology by the end of 2014, but we do not expect any new fees to be received before 2015, at the earliest. Due to the uncertainties inherent in the clinical research process and unknown future market conditions, there can be no assurance our ErepoXen ® technology will lead to any future fees. (Page 67) We expect our 2014 cash used in operating activities to be substantially higher than 2012 and 2013, predominantly directed at R&D activities in connection with our outside services and CROs. Since there are no milestone receipts expected to fall due during 2014, we do not expect any significant cash sources to be derived from revenues in 2014. (Page 69) Like many other Pharma`s we need a deal and the rest is history !

My concern is that under Erepoxen info, being the candidate most likely to lead to earliest revenue, my interpretation of the statement "The ErepoXen strategy, when implemented" on page 14 implies that we are not yet in a position to seek out licensing. So further fund raising this year is "Almost" inevitible unless we get great reults from Austrailia and a potential partner is prepared to pick up the TAB for the US approval process.?

Any thoughts how the next 6-9 months might unfold to get us onto the Nasdaq ? Erepoxen is the only drug in PH111 and although news is expected from Russia, it still all seems a bit premature for a deal and consequential income stream. We are also expecting Pulmoxen news and Oncohist but it's going to be down to the marketing to push up the SP. Why does his Lordship expect things to move swiftly to the dizzy heights of Nasdaq ? Certainly the building blocks are continually being added and we are holding the $1 mark quite well.

$0.98/1.6 then /3.125

I was told about the likely liquidity issue before delisting so no real surprise. I have been on board for four years and quite happy to wait another year for the real business plan to unfold. Not a share to trade by buying just before delisting due to the foreseen issues and the fact that in the US. - who are XBIO ? Be patient as Dutch advises and rewards will follow. No problem with liquidity after release of news, increased PR, increased SP and move to NASDAQ. Surely that's why we are here ! At a $1 each buy and don't sell, as per the non hesitant Baxter purchase !

My Broker is Rowan Dartington in Bristol. No price offered because I didnt ask him to sell any. He told me that he would call me when they could trade - the call came in today. I dont know anything about certificates, I just buy and sell all stocks through this broker and they handle the rest. Simple - but i have never had any problems with them.

I have just received a call from my broker that they can now trade my shares should i wish to. Happy days ! However - No selling from me.

Sorry, i forgot about the dual listing. So presumably the inverse effect ? More Zar so a good deal for them.

Just worth noting that they sell in GBP and the convert to ZAR. In the last 12 months the currency has devalued by 30% against GBP irrespective of the average SP of £0.15. These people are just watching their investment deminish irrespective of the company performance with a reletrively static SP. We buy and sell in GBP and the gold is sold in USD so i dont blame them selling if they live in SA with rising inflation.

Please not the reply from my broker regarding trading. I have no interest in selling, but its nice to know the current situation. "As originally thought, now they are trading OTC (over the counter) they are extremely illiquid. Having spoken to the relevant people in the market, I can confirm that the shares are being traded in blocks of 100 shares at $1.09 each. To try and sell anything bigger than 100 shares is going to be difficult and will have to be worked over a period of time, hopefully finding a buyer of size. We need the shares to be dematerialized which will take a couple of weeks. This process has started but is not yet complete".

Such fond memories from my first visit as a youngster, only to return in later life to experience chipped tea stained cups in the cafe followed by the multiple nicknack shops and of of course good old chippies ! Sounds a bit like the Lipoxex / Xen ride on Aim! Hopefully the US experience will be like riding "the Big One"

On a serious note - What has Noricum got to do with PAF or are you thinking of a possible offer ? The short term price movements seem to be related to POG. Results today have note moved this on but it looks like a RED day. Do you think the China Debt situation may continue to fuel the rally ?

What is the current SP now that all shares are issued - is $3 correct ?? Can any one recommend a stock quote site that actually shows the correct share issue / SP and daily volume ? The OTCBB site is very poor in my opinion. Arny - 17.22C seems sensible but where does it come from ?

When are we expecting the full share volume to hit the market with the ticker change to XBIO ? Interesting to see what SP this opens at when this takes place ! longer term hold for me with exciting times ahead. Just hope nothing silly happens with the USD.

News is well overdue on this one for both AML and NHL trials, where we were targeting updates in H1 2013. All quiet but as you say Dutch, expect more fireworks over the next few months as we march towards Nasdaq listing.

13,500,000 as the current consolidated share issue and not 13.500 !

As i am trying to understand our current SP. Is 13,500 the current consolidate share issue for GAIFD ? IE we received 56/175 which was then consolidated by 10:1 ? so this equates to Circa 2.6 x the Aim value of £0.06 ? for every 100K shares converting to 3200 consolidated. Aim value @ £6000/100,000 OTCBB value Circa £15500 based on £1 = $1.65 ?

Who will buy at $8 ? The current price is not realistic. However the marketing has began with a bang !

I wonder if this cash injection means that we wont need to place more shares into the market to raise capital ? No dilution in the near term ?